CBOA
ZBH icon

Commonwealth Bank of Australia’s Zimmer Biomet ZBH Stock Holding History

Commonwealth Bank of Australia’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18,374
Closed -$2.1M – 982
2019
Q2 		$2.1M Sell
18,374
-371
-2% -$43.5K 0.02% 389
2019
Q1 		$2.32M Buy
18,745
+103
+0.6% +$11.7K 0.02% 377
2018
Q4 		$1.87M Buy
18,642
+7,949
+74% +$894K 0.02% 385
2018
Q3 		$1.36M Buy
10,693
+1,957
+22% +$233K 0.01% 497
2018
Q2 		$940K Buy
8,736
+8,525
+4,040% +$928K 0.01% 523
2018
Q1 		$21K Sell
211
-618
-75% -$71.8K ﹤0.01% 693
2017
Q4 		$95K Sell
829
-1,002
-55% -$113K ﹤0.01% 617
2017
Q3 		$204K Sell
1,831
-7,833
-81% -$904K ﹤0.01% 602
2017
Q2 		$1.2M Sell
9,664
-2,918
-23% -$346K 0.01% 479
2017
Q1 		$1.49M Sell
12,582
-1,311
-9% -$149K 0.02% 417
2016
Q4 		$1.39M Sell
13,893
-147
-1% -$15.8K 0.02% 411
2016
Q3 		$1.77M Sell
14,040
-1,030
-7% -$127K 0.02% 351
2016
Q2 		$1.76M Buy
15,070
+517
+4% +$58.5K 0.02% 346
2016
Q1 		$1.51M Sell
14,553
-346
-2% -$33.5K 0.02% 372
2015
Q4 		$1.48M Sell
14,899
-1,786
-11% -$175K 0.02% 383
2015
Q3 		$1.52M Buy
16,685
+316
+2% +$31.7K 0.02% 382
2015
Q2 		$1.74M Sell
16,369
-594
-4% -$65.7K 0.02% 323
2015
Q1 		$1.94M Sell
16,963
-721
-4% -$82.3K 0.03% 305
2014
Q4 		$1.95M Sell
17,684
-5,982
-25% -$631K 0.03% 289
2014
Q3 		$2.31M Buy
23,666
+309
+1% +$30.4K 0.03% 291
2014
Q2 		$2.35M Sell
23,357
-19,410
-45% -$1.89M 0.03% 293
2014
Q1 		$3.93M Buy
42,767
+9,239
+28% +$852K 0.03% 494
2013
Q4 		$3.03M Buy
33,528
+3,206
+11% +$277K 0.02% 538
2013
Q3 		$2.42M Buy
30,322
+721
+2% +$56.8K 0.02% 558
2013
Q2 		$2.15M Buy
+29,601
New +$2.21M 0.02% 560

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commonwealth Bank of Australia's ZBH Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 18,374 shares — an estimated $2.1M sold.

Commonwealth Bank of Australia first reported a position in ZBH in Q2 2013 and held it in 25 quarters. The position peaked at $3.93M in Q1 2014. 897 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 18,374 Zimmer Biomet shares in Q3 2019, an estimated $2.1M.
  • Commonwealth Bank of Australia first reported a position in Zimmer Biomet in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Zimmer Biomet position peaked at $3.93M in Q1 2014.
  • 897 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.